Skip to Content

Haleon PLC ADR

HLN: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$7.20QjmwkHfgbzjl

Haleon Enjoys Independence From GSK and Builds Upon Its Leadership With Innovations and New Markets

Business Strategy and Outlook

Haleon is one of the largest consumer healthcare companies in the world. Over the last few years, Haleon has achieved a more rationalized operation by divesting multiple non-strategic brands, slimming down its manufacturing footprint, and dialing back the number of warehouses and distribution centers. We appreciate the company’s efforts to optimize its business and believe it is well established to enjoy long-term industry trends, including an aging population, premiumization of consumer healthcare products, and growing emerging markets, that should fuel its top line.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of HLN so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center